Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing dihydrotachysterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Product containing precisely dihydrotachysterol 125 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Dihydrotachysterol 170mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Dihydrotachysterol 0.2mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Product containing precisely dihydrotachysterol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Dihydrotachysterol 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Product containing precisely dihydrotachysterol 400 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
|
Product containing precisely dihydrotachysterol 125 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 125 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 200 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Dihydrotachysterol 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Dihydrotachysterol 125 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 400 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 400 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Dihydrotachysterol 125 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 400 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 125 microgram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing dihydrotachysterol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrotachysterol 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Dihydrotachysterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |
Dihydrotachysterol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dihydrotachysterol |
Inferred relationship |
Some |
1 |